Cheryl Gault
Förmögenhet: 6 M $ per 2026-06-30
Förmögenhet: 6 M $ per 2026-06-30
Cheryl Gault is currently Chief Operating Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Ms. Gault was Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023, VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019, and held the position Head-Sales & Marketing at Genzyme Corp.
Ms. Gault completed undergraduate education at Boston College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-30 | 149 914 ( 0,31 % ) | 6 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Verksamhetschef | 2023-09-07 |
| Företag | Position | Slut |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Verksamhetschef | 2023-07-28 |
| IRONWOOD PHARMACEUTICALS, INC. | Företagsledare/Principal | 2019-04-01 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Försäljning & Marknadsföring | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån